tiprankstipranks
Closing Bell Movers: Toast gains 19% afterhours after earnings beat
PremiumThe FlyClosing Bell Movers: Toast gains 19% afterhours after earnings beat
1M ago
RxSight reports Q3 adjusted EPS 0c, consensus (25c)
Premium
The Fly
RxSight reports Q3 adjusted EPS 0c, consensus (25c)
1M ago
RxSight sees FY24 revenue $139M-$140M, consensus $139.64M
Premium
The Fly
RxSight sees FY24 revenue $139M-$140M, consensus $139.64M
1M ago
Needham ups RxSight target to $66, adds to Conviction List
PremiumThe FlyNeedham ups RxSight target to $66, adds to Conviction List
4M ago
RxSight price target lowered to $65 from $72 at Oppenheimer
Premium
The Fly
RxSight price target lowered to $65 from $72 at Oppenheimer
5M ago
RxSight price target lowered to $65 from $70 at Stifel
Premium
The Fly
RxSight price target lowered to $65 from $70 at Stifel
5M ago
RxSight price target raised to $73 from $72 at BTIG
PremiumThe FlyRxSight price target raised to $73 from $72 at BTIG
5M ago
RxSight price target lowered to $70 from $75 at Stifel
Premium
The Fly
RxSight price target lowered to $70 from $75 at Stifel
5M ago
RxSight 1.79M share Spot Secondary priced at $56.00
Premium
The Fly
RxSight 1.79M share Spot Secondary priced at $56.00
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100